Benralizumab

Definition: Benralizumab, sold under the brand name Fasenra, is a monoclonal antibody directed against the alpha chain of the interleukin-5 receptor (CD125). It was developed by MedImmune for the treatment of asthma. It is currently marketed by Astrazeneca. source: Wikipedia

ID

763651005

ID date

7 Jan 2022

Previous ID

35061211000001103

Name

Benralizumab